Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 122, Issue 5, Pages 1717-1725
Publisher
American Society for Clinical Investigation
Online
2012-04-09
DOI
10.1172/jci60530
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-CD3 antibodies for type 1 diabetes: beyond expectations
- (2011) Jean-François Bach LANCET
- Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
- (2011) Diane K Wherrett et al. LANCET
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
- (2011) Tom L. Van Belle et al. PHYSIOLOGICAL REVIEWS
- Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group
- (2010) J. B. Matthews et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
- (2010) M. Peakman et al. DIABETES
- Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial
- (2010) J. Ludvigsson et al. DIABETOLOGIA
- Immunotherapy of Type 1 Diabetes: Where Are We and Where Should We Be Going?
- (2010) Xunrong Luo et al. IMMUNITY
- Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic mice
- (2010) Devangi S. Mehta et al. IMMUNOLOGY
- Immunotherapy of type 1 diabetes — How to rationally prioritize combination therapies in T1D
- (2010) Tobias Boettler et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Modulation of Gut-Associated Lymphoid Tissue Functions with Genetically ModifiedLactococcus lactis
- (2010) Pieter Rottiers et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Genetics, pathogenesis and clinical interventions in type 1 diabetes
- (2010) Jeffrey A. Bluestone et al. NATURE
- Actobiotics™ as a Novel Method for Cytokine Delivery
- (2009) Lothar Steidler et al. Annals of the New York Academy of Sciences
- Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients
- (2009) B. Keymeulen et al. BLOOD
- Induction of Antigen-Specific Tolerance by Oral Administration of Lactococcus lactis Delivered Immunodominant DQ8-Restricted Gliadin Peptide in Sensitized Nonobese Diabetic Ab Dq8 Transgenic Mice
- (2009) I. L. Huibregtse et al. JOURNAL OF IMMUNOLOGY
- Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis
- (2009) Masako Murai et al. NATURE IMMUNOLOGY
- Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study
- (2008) S. L. Thrower et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Innate immunity and intestinal microbiota in the development of Type 1 diabetes
- (2008) Li Wen et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started